D
Dimitrios Drougas
Publications - 3
Citations - 45
Dimitrios Drougas is an academic researcher. The author has contributed to research in topics: Nivolumab & Lung cancer. The author has an hindex of 3, co-authored 3 publications receiving 37 citations.
Papers
More filters
Journal ArticleDOI
Immunotherapy "Shock" with vitiligo due to nivolumab administration as third line therapy in lung adenocarcinoma.
Paul Zarogoulidis,Haidong Huang,Theodora Tsiouda,Chrysa Sardeli,Georgia Trakada,Lemonia Veletza,Anastasios Kallianos,Christoforos Kosmidis,Aggeliki Rapti,Liana Papaemmanouil,Dimitrios Hatzibougias,Dimitrios Drougas,Chong Bai,Wolfgang Hohenforst-Schmidt +13 more
TL;DR: A rare case of a patient with lung cancer adenocarcinoma who developed vitiligo throughout his body after nivolumab administration is reported.
Journal ArticleDOI
Psoriatic arthritis due to nivolumab administration a case report and review of the literature.
Konstantinos Sapalidis,Christoforos Kosmidis,Nikolaos V. Michalopoulos,Charilaos Koulouris,Stylianos Mantalobas,Dimitrios Giannakidis,Alexandru Claudiu Munteanu,Valeriu Surlin,Stella Laskou,Paul Zarogoulidis,Dimitrios Drougas,Crysanthi Sardeli,Chrysanthi Karapantzou,Ilias Karapantzos,Wolfgang Hohenforst-Schmidt,Haidong Huang,Isaak Kesisoglou +16 more
TL;DR: A rare case of psoriacic arthritis that was presented after two cycles of nivolumab administration is presented and a review of the literature is presented.
Journal ArticleDOI
Immunotherapy "Shock" a case series of PD-L1 100% and pembrolizumab first-line treatment.
Paul Zarogoulidis,Evaggelia Athanasiou,Theodora Tsiouda,Dimitrios Hatzibougias,Haidong Huang,Chong Bai,Georgia Trakada,Lemonia Veletza,Anastasios Kallianos,Christoforos Kosmidis,Nikolaos Barbetakis,Dimitrios Paliouras,Aggeliki Rapti,Dimitrios Drougas,Wolfgang Hohenforst-Schmidt +14 more
TL;DR: In this decade a “bloom” of novel therapies has been observed for non-small cell lung cancer, and new tools for the diagnosis of lung cancer and also the ability to re-biospy easier than before in different lesions and obtain tissue samples in order to investigate whether a patient can receive new targeted therapies.